BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24704894)

  • 1. Antidepressants for depression in patients with dementia: a review of the literature.
    Leong C
    Consult Pharm; 2014 Apr; 29(4):254-63. PubMed ID: 24704894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.
    Köhler-Forsberg O; Stiglbauer V; Brasanac J; Chae WR; Wagener F; Zimbalski K; Jefsen OH; Liu S; Seals MR; Gamradt S; Correll CU; Gold SM; Otte C
    JAMA Psychiatry; 2023 Dec; 80(12):1196-1207. PubMed ID: 37672261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Depression in Dementia Patients: A Risk or Remedy-A Narrative Review.
    Sultan S
    Geriatrics (Basel); 2024 May; 9(3):. PubMed ID: 38804321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence.
    Henry G; Williamson D; Tampi RR
    Am J Alzheimers Dis Other Demen; 2011 May; 26(3):169-83. PubMed ID: 21429956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant drug effects and depression severity: a patient-level meta-analysis.
    Fournier JC; DeRubeis RJ; Hollon SD; Dimidjian S; Amsterdam JD; Shelton RC; Fawcett J
    JAMA; 2010 Jan; 303(1):47-53. PubMed ID: 20051569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.
    Howard R; Cort E; Rawlinson C; Wiegand M; Downey A; Lawrence V; Banerjee S; Bentham P; Fox C; Harwood R; Hunter R; Livingston G; Moniz-Cook E; Panca M; Raczek M; Ivenso C; Russell G; Thomas A; Wilkinson P; Freemantle N; Gould R
    Alzheimers Dement; 2024 Apr; 20(4):2990-2999. PubMed ID: 38477423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature.
    Ozkan B; Wilkins K; Muralee S; Tampi RR
    Am J Alzheimers Dis Other Demen; 2008; 23(4):344-54. PubMed ID: 18509106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.
    Moraros J; Nwankwo C; Patten SB; Mousseau DD
    Depress Anxiety; 2017 Mar; 34(3):217-226. PubMed ID: 28029715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence.
    Bhivandkar S; Sarfraz Z; Jain L; Bachu A; Malo PK; Hsu M; Ayub S; Poudel L; Kumar H; Loh H; Tazin F; Ahmed S; Suzuki J
    J Clin Med Res; 2024 Mar; 16(2-3):46-55. PubMed ID: 38550549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review.
    Rutherford BR; Mori S; Sneed JR; Pimontel MA; Roose SP
    J Psychiatr Res; 2012 Jun; 46(6):697-702. PubMed ID: 22410207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
    Sharma A; Gerbarg P; Bottiglieri T; Massoumi L; Carpenter LL; Lavretsky H; Muskin PR; Brown RP; Mischoulon D;
    J Clin Psychiatry; 2017 Jun; 78(6):e656-e667. PubMed ID: 28682528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Depression in Huntington's Disease: A Systematic Review.
    Zadegan SA; Ramirez F; Reddy KS; Sahin O; Rocha NP; Teixeira AL; Furr Stimming E
    J Neuropsychiatry Clin Neurosci; 2024 Mar; ():appineuropsych20230120. PubMed ID: 38528808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating Resistance to Antidepressants in Animal Models.
    Peña JE; Corbett BF; Tamminga CA; Bhatnagar S; Hitti FL
    Neuroscience; 2024 Jun; 548():69-80. PubMed ID: 38697464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical approach to detection and treatment of depression in Parkinson disease and dementia.
    Goodarzi Z; Ismail Z
    Neurol Clin Pract; 2017 Apr; 7(2):128-140. PubMed ID: 28409063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
    Mokhber N; Abdollahian E; Soltanifar A; Samadi R; Saghebi A; Haghighi MB; Azarpazhooh A
    Pharmacopsychiatry; 2014 Jul; 47(4-5):131-40. PubMed ID: 24955552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments.
    Khundakar AA; Thomas AJ
    J Alzheimers Dis; 2015; 44(1):27-41. PubMed ID: 25208623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis.
    Wang J; Yu JT; Wang HF; Meng XF; Wang C; Tan CC; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):101-9. PubMed ID: 24876182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
    Ford AH; Almeida OP
    Drugs Aging; 2017 Feb; 34(2):89-95. PubMed ID: 28074409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the therapeutic value of antidepressants in dementia? A narrative review.
    Farina N; Morrell L; Banerjee S
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):32-49. PubMed ID: 27593707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.